Le Lézard
Classified in: Health, Business
Subject: ECO

Report: Hospitals Contribute $23.4 Billion to N.J. Economy


PRINCETON, N.J., Dec. 8, 2017 /PRNewswire-USNewswire/ -- New Jersey hospitals and health systems contributed $23.4 billion to the Garden State economy in 2016, according to the 2017 N.J. Hospitals Economic Impact Report released today by the New Jersey Hospital Association. This is an increase from $22.7 billion in activity in 2015.

Hospitals Contribute $23.4 Billion to N.J. Economy

Mirroring national trends, hospitals and health systems saw employment increase to nearly 144,000 jobs, including more than 120,000 full-time jobs. This resulted in $9 billion in employee payroll spending and $496 million in estimated state income tax paid by employees, an increase from $8.7 billion and $483 million in 2015, respectively.

"New Jersey's hospitals and health systems are some of the largest employers in the state, not only providing quality care to their communities and supporting community health and wellness, but contributing to the financial strength and producing jobs people are proud to do," said Cathy Bennett, president and CEO of NJHA. "We are gratified our work is a bedrock of the state and local economy."

The Economic Impact Report uses data gathered from 71 acute care hospitals in the Garden State and compiles their economic contributions statewide and across counties and individual hospitals. The 2017 report, which utilizes 2016 year-end data, also breaks out economic contributions by hospital- and county-level data.

The full report is available as an interactive tool for the second year, available here (http://www.njha.com/resources/2017-economic-impact-report/). Data by teaching hospital status and state and federal district is also easily accessed through a series of drop down menus. Previous reports dating back to 2014 data are also available now through the interactive page.

Specific highlights from the 2017 report include:

"As the full impact of the aging Baby Boomer generation is just beginning to be felt, the true value of the hospitals and health systems to the state of New Jersey cannot be overstated. The economic footprint of our healthcare community ripples throughout state and local economies and provides a strong foundation for continuing to provide excellent care to the people of our state," said Sean Hopkins, NJHA's senior vice president of federal relations and health economics.

NJHA reports also quantify the contributions of the state's nursing homes (http://www.njha.com/media/404009/NJHA2017NursingHomeProfile.pdf) and the $2.75 billion in community support provided by the state's hospitals and health systems (http://www.njha.com/media/413753/17-community-benefit-infographic-report.pdf).

 

SOURCE New Jersey Hospital Association (NJHA)


These press releases may also interest you

at 10:19
Revvity's EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits...

at 10:17
Fx Chocolate®, a Designs for Health brand that provides functional amounts of high-quality supplements in handcrafted chocolate, today announced the launch of its Yes Whey!!!tm chocolate supplement bar. Yes Whey!!!tm harnesses 15 grams of...

at 10:16
Varian, a Siemens Healthineers Company, announces its collaboration with BaraSeen Medical Company to introduce the first Halcyon system in Saudi Arabia - with its hallmark sustainability features - at BaraSeen's initial specialized standalone Batik-X...

at 10:15
From the childhood dream of becoming a veterinarian and saving the lives of pets, to today's realities of practicing veterinary medicine, the deep commitment veterinarians feel for their calling remains unchanged. However, certain factors make that...

at 10:12
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....



News published on and distributed by: